7 Andreas Halvorsen Inhibrx Biosciences Trades
The first Inhibrx Biosciences trade was made in Q3 2020. Since then Andreas Halvorsen bought shares three more times and sold shares on three occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Inhibrx Biosciences anymore.
Avg closing price
Price range
Sold -7.15 Million shares
May 30, 2024
Avg closing price
$15.86
Price range
$15.86
-
$15.86
Increased shares by 84.4% (+3.27 Million shares)
Q3 2023
Avg closing price
$20.92
Price range
$15.75
-
$26.31
Sold 41.6% shares (-2.76 Million shares)
Aug 28, 2023
Avg closing price
$19.35
Price range
$19.35
-
$19.35
Increased shares by 71.2% (+2.76 Million shares)
Q4 2022
Avg closing price
$29.39
Price range
$20.18
-
$33.33
Sold 26.9% shares (-1.43 Million shares)
Oct 07, 2022
Avg closing price
$30.50
Price range
$30.50
-
$30.50
Increased shares by 36.8% (+1.43 Million shares)
Q3 2020
Avg closing price
$18.12
Price range
$16.77
-
$20.65
New holding (+3.88 Million shares)
Aug 21, 2020
Avg closing price
$20.43
Price range
$20.43
-
$20.43
News about Inhibrx Biosciences Inc. and Andreas Halvorsen
Andreas Halvorsen''s Firm Ups Inhibrx Stake
Andreas Halvorsen''s Firm Ups Inhibrx Stake
Andreas Halvorsen's Firm Ups Inhibrx Stake
Viking Global Investors, the investment firm founded by Andreas Halvorsen (Trades, Portfolio) in 1999, disclosed earlier this week it boosted its stake in In...
Inhibrx Announces $200 Million Private Placement Financing
SAN DIEGO , Aug. 29, 2023 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company dedicated to ...